We serve Chemical Name:2-methyl-N-propan-2-ylpropanamide CAS:869-07-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-methyl-N-propan-2-ylpropanamide
CAS.NO:869-07-8
Synonyms:Isobuttersaeure-isopropylamid;N1-isopropyl-2-methylpropanamide;N-Isopropyl-2-methylpropanamide;N-isopropyl-isobutyramide;Isobutylamide,N-isopropyl;Propanamide,N-isopropyl-2-methyl;N-Isopropyl-isobutyramid;Isobutyrylisopropylamin
Molecular Formula:C7H15NO
Molecular Weight:129.20000
HS Code:2924199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:208.7ºC at 760mmHg
Density:0.856g/cm3
Index of Refraction:1.418
PSA:29.10000
Exact Mass:129.11500
LogP:1.55790
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Isobuttersaeure-isopropylamid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Isobutyrylisopropylamin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Propanamide,N-isopropyl-2-methyl Use and application,N-isopropyl-isobutyramide technical grade,usp/ep/jp grade.
Related News: If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 2-methyl-N-propan-2-ylpropanamide manufacturer If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 2-methyl-N-propan-2-ylpropanamide supplier More than 2,000 new cases were also recorded in the country in the past 24 hours, raising the worldwide total to nearly 14,380, according to Chinese and World Health Organization data. The vast majority of the cases are inside China; about 100 cases have been confirmed in at least 23 other countries. 2-methyl-N-propan-2-ylpropanamide vendor Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 2-methyl-N-propan-2-ylpropanamide factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.
